Impact of empagliflozin on quality-of-life in real-world patients with heart failure: insights from the multinational Emp-Activity study

29 August 2025 (11:15 - 11:25)
Organised by: Logo
Congress Presentation Part of: Evolving strategies in heart failure management Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by